PL2501704T3 - Spiropiperydynowe związki jako antagoniści receptora ORL-1 - Google Patents
Spiropiperydynowe związki jako antagoniści receptora ORL-1Info
- Publication number
- PL2501704T3 PL2501704T3 PL10782486T PL10782486T PL2501704T3 PL 2501704 T3 PL2501704 T3 PL 2501704T3 PL 10782486 T PL10782486 T PL 10782486T PL 10782486 T PL10782486 T PL 10782486T PL 2501704 T3 PL2501704 T3 PL 2501704T3
- Authority
- PL
- Poland
- Prior art keywords
- antagagonisten
- receptor
- oral
- spiropiperidine compounds
- spiropiperidine
- Prior art date
Links
- JUXAVSAMVBLDKO-UHFFFAOYSA-N 1-(1-azabicyclo[2.2.2]octan-3-yl)-3-[3-(1h-indol-3-yl)-1-oxo-1-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylpropan-2-yl]urea Chemical class C1N(CC2)CCC2C1NC(=O)NC(C(=O)N1CCC2(C3=CC=CC=C3CC2)CC1)CC1=CNC2=CC=CC=C12 JUXAVSAMVBLDKO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382245 | 2009-11-16 | ||
| US29862810P | 2010-01-27 | 2010-01-27 | |
| EP10782486.4A EP2501704B1 (en) | 2009-11-16 | 2010-11-12 | Spiropiperidine compounds as oral-1 receptor antagagonisten |
| PCT/US2010/056449 WO2011060217A1 (en) | 2009-11-16 | 2010-11-12 | Spiropiperidine compounds as orl-1 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2501704T3 true PL2501704T3 (pl) | 2014-02-28 |
Family
ID=41800752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10782486T PL2501704T3 (pl) | 2009-11-16 | 2010-11-12 | Spiropiperydynowe związki jako antagoniści receptora ORL-1 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120214784A1 (pl) |
| EP (1) | EP2501704B1 (pl) |
| JP (1) | JP5723381B2 (pl) |
| KR (1) | KR101368130B1 (pl) |
| CN (1) | CN102666550B (pl) |
| AU (1) | AU2010319400B2 (pl) |
| BR (1) | BR112012011710A2 (pl) |
| CA (1) | CA2781041C (pl) |
| DK (1) | DK2501704T3 (pl) |
| EA (1) | EA020391B1 (pl) |
| ES (1) | ES2436241T3 (pl) |
| HR (1) | HRP20130969T1 (pl) |
| MX (1) | MX2012005690A (pl) |
| PL (1) | PL2501704T3 (pl) |
| PT (1) | PT2501704E (pl) |
| RS (1) | RS53017B (pl) |
| SI (1) | SI2501704T1 (pl) |
| WO (1) | WO2011060217A1 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2781716A1 (en) | 2009-12-04 | 2011-06-09 | Sunovion Pharmaceuticals Inc. | Multicyclic thieno compounds and use thereof for the treatment of a neurological disorder |
| TWI582096B (zh) * | 2011-12-06 | 2017-05-11 | 美國禮來大藥廠 | 用於酒精依賴及濫用處理之４',５'－二氫螺［哌啶－４,７'－噻吩并[２，３－c]哌喃］化合物 |
| TW201416370A (zh) | 2012-07-31 | 2014-05-01 | Lilly Co Eli | 用於治療焦慮之ｏｒｌ－１受體拮抗劑 |
| JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
| JO3638B1 (ar) * | 2015-09-09 | 2020-08-27 | Lilly Co Eli | مركبات مفيدة في تثبيط ror - جاما- t |
| SG10202100751YA (en) | 2016-07-29 | 2021-03-30 | Sunovion Pharmaceuticals Inc | Compounds and compositions and uses thereof |
| AU2017301769B2 (en) | 2016-07-29 | 2022-07-28 | Pgi Drug Discovery Llc | Compounds and compositions and uses thereof |
| EP3497101B1 (de) | 2016-08-10 | 2020-12-30 | Bayer CropScience Aktiengesellschaft | Substituierte 2-heterocyclyl-imidazolyl-carboxamide als schädlingsbekämpfungsmittel |
| AU2018220509B2 (en) | 2017-02-16 | 2022-04-28 | Sumitomo Pharma America, Inc. | Methods of treating schizophrenia |
| EP3589637B1 (en) * | 2017-03-02 | 2021-04-14 | Eli Lilly and Company | Compounds useful for inhibiting ror-gamma-t |
| HRP20210898T1 (hr) | 2017-03-02 | 2021-08-20 | Eli Lilly And Company | SPOJEVI KORISNI ZA INHIBIRANJE ROR-γ-T |
| SG11202000669VA (en) | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
| CA3091292A1 (en) | 2018-02-16 | 2019-08-22 | Sunovion Pharmaceuticals Inc. | Salts, crystal forms, and production methods thereof |
| CN113453760B (zh) | 2018-12-17 | 2024-05-24 | 弗特克斯药品有限公司 | Apol1抑制剂及其使用方法 |
| JP7703449B2 (ja) | 2019-03-14 | 2025-07-07 | スミトモ・ファーマ・アメリカ・インコーポレイテッド | イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物 |
| EP3766879A1 (en) | 2019-07-19 | 2021-01-20 | Basf Se | Pesticidal pyrazole derivatives |
| CN115734785A (zh) | 2020-04-14 | 2023-03-03 | 桑诺维恩药品公司 | (S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症 |
| CA3183591A1 (en) | 2020-06-12 | 2021-12-16 | Vertex Pharmaceuticals Incorporated | Solid forms of apol1 inhibitor and using the same |
| IL300298B2 (en) | 2020-08-26 | 2025-06-01 | Vertex Pharma | Inhibitors of apol1 and methods of using same |
| JP2025505647A (ja) * | 2022-02-08 | 2025-02-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ａｐｏｌ１阻害剤としての２－メチル－４’，５’－ジヒドロピロ［ピペリジン－４，７’－チエノ［２，３－ｃ］ピラン］誘導体、およびそれを使用する方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003095427A1 (en) | 2002-05-10 | 2003-11-20 | Taisho Pharmaceutical Co.,Ltd. | Spiro-ring compound |
| WO2005016913A1 (en) * | 2003-08-19 | 2005-02-24 | Pfizer Japan, Inc. | Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
| DE10360792A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| WO2005092858A2 (en) * | 2004-03-29 | 2005-10-06 | Pfizer Japan Inc. | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist |
| DE102004039382A1 (de) * | 2004-08-13 | 2006-02-23 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| US7655670B2 (en) * | 2005-06-02 | 2010-02-02 | Janssen Pharmaceutica N.V. | 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators |
-
2010
- 2010-11-12 KR KR1020127012503A patent/KR101368130B1/ko not_active Expired - Fee Related
- 2010-11-12 HR HRP20130969AT patent/HRP20130969T1/hr unknown
- 2010-11-12 SI SI201030389T patent/SI2501704T1/sl unknown
- 2010-11-12 DK DK10782486.4T patent/DK2501704T3/da active
- 2010-11-12 PL PL10782486T patent/PL2501704T3/pl unknown
- 2010-11-12 AU AU2010319400A patent/AU2010319400B2/en not_active Ceased
- 2010-11-12 EA EA201290355A patent/EA020391B1/ru not_active IP Right Cessation
- 2010-11-12 CA CA2781041A patent/CA2781041C/en not_active Expired - Fee Related
- 2010-11-12 JP JP2012538997A patent/JP5723381B2/ja active Active
- 2010-11-12 EP EP10782486.4A patent/EP2501704B1/en active Active
- 2010-11-12 BR BR112012011710A patent/BR112012011710A2/pt active Search and Examination
- 2010-11-12 CN CN201080051845.3A patent/CN102666550B/zh not_active Expired - Fee Related
- 2010-11-12 US US13/504,176 patent/US20120214784A1/en not_active Abandoned
- 2010-11-12 ES ES10782486T patent/ES2436241T3/es active Active
- 2010-11-12 WO PCT/US2010/056449 patent/WO2011060217A1/en not_active Ceased
- 2010-11-12 PT PT107824864T patent/PT2501704E/pt unknown
- 2010-11-12 MX MX2012005690A patent/MX2012005690A/es active IP Right Grant
- 2010-11-12 RS RS20130484A patent/RS53017B/sr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20130969T1 (hr) | 2013-11-22 |
| US20120214784A1 (en) | 2012-08-23 |
| CA2781041A1 (en) | 2011-05-19 |
| ES2436241T3 (es) | 2013-12-27 |
| EA020391B1 (ru) | 2014-10-30 |
| KR20120082927A (ko) | 2012-07-24 |
| EA201290355A1 (ru) | 2012-10-30 |
| AU2010319400B2 (en) | 2013-12-19 |
| EP2501704B1 (en) | 2013-09-18 |
| WO2011060217A1 (en) | 2011-05-19 |
| AU2010319400A1 (en) | 2012-06-07 |
| RS53017B (sr) | 2014-04-30 |
| CA2781041C (en) | 2015-01-06 |
| JP2013510870A (ja) | 2013-03-28 |
| DK2501704T3 (da) | 2013-10-14 |
| JP5723381B2 (ja) | 2015-05-27 |
| SI2501704T1 (sl) | 2013-11-29 |
| EP2501704A1 (en) | 2012-09-26 |
| KR101368130B1 (ko) | 2014-02-27 |
| CN102666550B (zh) | 2015-07-15 |
| CN102666550A (zh) | 2012-09-12 |
| MX2012005690A (es) | 2012-06-13 |
| BR112012011710A2 (pt) | 2016-03-01 |
| PT2501704E (pt) | 2013-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2501704T1 (sl) | Spojine spiropiperidina kot antagonisti oral-1 receptorja | |
| HRP20180615T1 (hr) | Tetraciklički spojevi | |
| IL219594A0 (en) | Novel spiropiperidine compounds | |
| ZA201107772B (en) | Substituted spiro-amide compounds | |
| GB0907425D0 (en) | Compounds | |
| EP2393493A4 (en) | LINKS | |
| GB0907515D0 (en) | Compounds | |
| IL219370A0 (en) | Spiropiperidine compounds as orl-1 receptor antagonists | |
| ZA201205726B (en) | Substituted naphthalenyl-pyrimidine compounds | |
| GB0905641D0 (en) | Compounds | |
| GB0909671D0 (en) | Compounds | |
| GB0909672D0 (en) | Compounds | |
| AP2909A (en) | Pyrazinoisoquinoline Compounds | |
| EP2443115A4 (en) | COMPOUNDS | |
| GB0903492D0 (en) | Compounds | |
| GB0906853D0 (en) | Compounds | |
| GB0904746D0 (en) | Compounds | |
| GB0905054D0 (en) | Compounds | |
| GB0905057D0 (en) | Compounds | |
| GB0905060D0 (en) | Compounds | |
| GB0903948D0 (en) | Compounds | |
| GB0905932D0 (en) | Compounds | |
| GB0906378D0 (en) | Compounds | |
| GB0904729D0 (en) | Compounds | |
| GB0906854D0 (en) | Compounds |